Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study.

Acta gastro-enterologica Belgica

Volumn 73, Issue 1, 2010, Pages 5-11

  Van Vlierberghe, H ^a   Adler, M ^b   Bastens, B ^b   Colle, I ^b   Delwaide, J ^b   Henrion, J ^b   Horsmans, Y ^b   Michielsen, P ^b   Golstein, P ^b   Mulkay, J P ^b   Van Steenbergen, W ^b   Yap, P ^b   Nevens, F ^b   Denys, A M ^b   Brasseur, J P ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2B; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ARTICLE; BELGIUM; COHORT ANALYSIS; DRUG COMBINATION; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; BELGIUM; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 77954098309     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)